Share this article and save a life!
The ICU just got its first thinking brain drain.
The FDA approved something remarkable yesterday: an AI system that autonomously manages brain pressure in critically ill patients.
BrainSpace’s Intellidrop doesn’t just monitor intracranial pressure. It actively drains cerebrospinal fluid using closed-loop AI, adjusting in real-time to each patient’s personalized pressure goals.
Think about what this means:
Every year, millions of patients with traumatic brain injuries, strokes, or post-surgical complications need precise CSF drainage. One wrong measurement, one delayed adjustment, and you risk permanent brain damage or death.
Until now, this required constant manual monitoring by specialized neuro ICU nurses, already stretched impossibly thin.
📊 The numbers are staggering:
• 1 in 3 people globally will face neurological injury or illness
• ICUs are operating with 20% nursing vacancy rates
• Brain pressure management errors contribute to 30% of neuro ICU complications
But here’s what really excites me:
This isn’t just automation. It’s the birth of Brain Fluid Interface technology, a new category that treats brain fluids as data streams for AI analysis.
The device generates multimodal, contextualized data that trains Physical AI models. We’re literally teaching machines to understand the language of cerebrospinal fluid.
Imagine AI that predicts strokes before symptoms appear. Or systems that detect early Alzheimer’s through CSF patterns. Or personalized brain pressure algorithms that adapt to each patient’s unique neurological fingerprint.
The skeptics will say we’re replacing human judgment with algorithms. But when one neuro ICU nurse manages 4 critical patients simultaneously, isn’t AI augmentation the ethical choice?
This approval signals something bigger: the FDA is ready for autonomous medical AI that makes real-time clinical decisions.
We’re not just monitoring patients anymore. We’re creating intelligent guardians that never sleep, never fatigue, and learn from every patient they treat.
The brain-computer interface revolution isn’t coming through Neuralink.
It’s already here, quietly draining fluid in ICUs across America.
♻️ Repost if AI should guard our most vulnerable organ
👉 Follow me, Jonathan Govette, for real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
